@FierceBiotech: Troubled Genzyme launches probe into insider trading claims. Article | Follow @FierceBiotech
@JohnCFierce: 15 VC-backed companies traded hands last week. So is the party back on yet? Nope. Report | Follow @JohnCFierce
> The FDA has noted that a clinical trial of GlaxoSmithKline's Promacta was halted after researchers spotted a higher rate of blood clots among patients taking the drug compared with the placebo arm. Promacta had been in a trial for chronic immune idiopathic thrombocytopenic purpura triggered by no known cause. The trial involved patients with ITP triggered by liver damage. Story
> Resverlogix says it has halted enrollment in a clinical trial to test a treatment for thickening of the arteries. The developer says it wants to modify its enrollment procedures, news that sent its shares down about 7 percent. Report
> Nuon Therapeutics named Lee Rauch president and CEO. Recently, she held the position of acting head of corporate development for Onyx Pharmaceuticals. Nuon release
> Colorado State University has opened a new, $53 million life sciences incubator. Report
> Irvine, CA-based Cobalis has named Martin Marion as its new chief executive officer. Cobalis release
And Finally... Walgreens has dropped the idea of selling a genetic home test after the FDA opened an investigation of the supplier, Pathway Genetics, and its product. Report